• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用尿液代谢物浓度调查丁丙诺啡相关死亡。

Investigation of buprenorphine-related deaths using urinary metabolite concentrations.

机构信息

Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.

Forensic Toxicology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

出版信息

Drug Test Anal. 2022 Oct;14(10):1696-1702. doi: 10.1002/dta.3347. Epub 2022 Jul 18.

DOI:10.1002/dta.3347
PMID:35834288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9796430/
Abstract

Quantitative analysis of postmortem urine, instead of blood, for buprenorphine and metabolites may provide additional evidence for the diagnosis of fatal buprenorphine poisoning. In this study, 247 autopsy urine samples, previously testing positive for buprenorphine or norbuprenorphine, were quantitatively reanalysed with a recently developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for unconjugated buprenorphine (BUP), norbuprenorphine (NBUP), naloxone (NAL), and their respective conjugated metabolites, buprenorphine glucuronide (BUPG), norbuprenorphine glucuronide (NBUPG), and naloxone glucuronide (NALG). The cases were divided, according to medical examiners' decision, to buprenorphine poisonings and other causes of death. The groups were compared for urinary concentrations and metabolite concentration ratios of the six analytes. All median concentrations were higher in the buprenorphine poisoning group. The median concentration of BUPG was significantly higher and the median metabolite ratios NBUP/BUP, NBUPG/BUPG, and NBUPtotal/BUPtotal were significantly lower in poisonings than in other causes of death. Naloxone-related concentrations and ratios were not significantly different between the groups.

摘要

对死后尿液(而非血液)进行定量分析,可能为致命性丁丙诺啡中毒的诊断提供更多证据。在本研究中,我们使用最近开发的液相色谱-串联质谱(LC-MS/MS)方法,对 247 例先前检测出丁丙诺啡或去甲丁丙诺啡阳性的尸检尿液样本进行了重新定量分析,用于检测未结合的丁丙诺啡(BUP)、去甲丁丙诺啡(NBUP)、纳洛酮(NAL)及其各自的结合代谢物丁丙诺啡葡萄糖醛酸(BUPG)、去甲丁丙诺啡葡萄糖醛酸(NBUPG)和纳洛酮葡萄糖醛酸(NALG)。根据法医的决定,将这些案例分为丁丙诺啡中毒和其他死因。比较了两组尿液中六种分析物的浓度和代谢物浓度比。丁丙诺啡中毒组的所有中位数浓度均较高。BUPG 的中位数浓度明显更高,中毒组的 NBUP/BUP、NBUPG/BUPG 和 NBUPtotal/BUPtotal 代谢物比值明显低于其他死因。两组之间纳洛酮相关浓度和比值无显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1350/9796430/13ddb51bfe1d/DTA-14-1696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1350/9796430/13ddb51bfe1d/DTA-14-1696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1350/9796430/13ddb51bfe1d/DTA-14-1696-g002.jpg

相似文献

1
Investigation of buprenorphine-related deaths using urinary metabolite concentrations.利用尿液代谢物浓度调查丁丙诺啡相关死亡。
Drug Test Anal. 2022 Oct;14(10):1696-1702. doi: 10.1002/dta.3347. Epub 2022 Jul 18.
2
Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定尿液中的丁丙诺啡、去甲丁丙诺啡、纳洛酮及其葡萄糖醛酸结合物。
Drug Test Anal. 2021 Sep;13(9):1658-1667. doi: 10.1002/dta.3104. Epub 2021 Jun 3.
3
Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法检测尿液中的游离(未结合)丁丙诺啡、去甲丁丙诺啡及其葡萄糖醛酸苷。
J Anal Toxicol. 2012 Mar;36(2):81-7. doi: 10.1093/jat/bkr020.
4
The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.采用液相色谱-电喷雾电离-串联质谱法测定丁丙诺啡和去甲丁丙诺啡的体内葡萄糖醛酸化作用。
Ther Drug Monit. 2006 Apr;28(2):245-51. doi: 10.1097/01.ftd.0000197094.92559.b4.
5
Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.采用液相色谱-串联质谱法对尿液中的丁丙诺啡、去甲丁丙诺啡、丁丙诺啡葡萄糖醛酸苷、去甲丁丙诺啡葡萄糖醛酸苷和纳洛酮进行定量分析。
Methods Mol Biol. 2016;1383:69-78. doi: 10.1007/978-1-4939-3252-8_8.
6
Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.阿片类药物替代治疗患者指甲剪屑和尿液中丁丙诺啡、去甲丁丙诺啡和纳洛酮的测定。
J Anal Toxicol. 2015 May;39(4):313-20. doi: 10.1093/jat/bkv003. Epub 2015 Feb 7.
7
Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.采用液相色谱-质谱联用技术同时定量测定人胎盘中的丁丙诺啡、去甲丁丙诺啡、丁丙诺啡葡萄糖醛酸苷和去甲丁丙诺啡葡萄糖醛酸苷。
Anal Bioanal Chem. 2009 May;394(2):513-22. doi: 10.1007/s00216-009-2706-z. Epub 2009 Feb 27.
8
Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.采用液相色谱串联质谱法同时测定人脐带中丁丙诺啡、去甲丁丙诺啡、丁丙诺啡葡萄糖醛酸苷和去甲丁丙诺啡葡萄糖醛酸苷的含量。
Forensic Sci Int. 2009 Jul 1;188(1-3):144-51. doi: 10.1016/j.forsciint.2009.04.005. Epub 2009 Apr 29.
9
Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法同时测定血浆中的丁丙诺啡、去甲丁丙诺啡和丁丙诺啡葡萄糖醛酸苷。
J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):447-59. doi: 10.1016/s0378-4347(01)00029-9.
10
Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes.用于执法药物分析的血液样本中的丁丙诺啡及其主要代谢物。
Forensic Sci Int. 2010 Feb 25;195(1-3):73-7. doi: 10.1016/j.forsciint.2009.11.015. Epub 2009 Dec 16.

引用本文的文献

1
Fatalities in opioid agonist treatment with long-acting injectable buprenorphine.长效注射用丁丙诺啡进行阿片类激动剂治疗时的死亡情况。
Int J Legal Med. 2025 Jun 18. doi: 10.1007/s00414-025-03535-w.
2
Buprenorphine deaths confirmed by toxicology reveal a low proportion of opioid agonist treatment before death in Finland.毒理学确认的丁丙诺啡死亡案例表明,在芬兰,死亡前接受阿片类激动剂治疗的比例较低。
Int J Legal Med. 2024 Nov;138(6):2331-2338. doi: 10.1007/s00414-024-03273-5. Epub 2024 Jun 24.

本文引用的文献

1
Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats.布比卡因和地西泮联合用药致大鼠呼吸抑制的机制。
Br J Anaesth. 2022 Mar;128(3):584-595. doi: 10.1016/j.bja.2021.10.029. Epub 2021 Dec 4.
2
Buprenorphine-Related Deaths in North Carolina from 2010 to 2018.北卡罗来纳州 2010 年至 2018 年与丁丙诺啡相关的死亡人数。
J Anal Toxicol. 2021 Sep 17;45(8):780-791. doi: 10.1093/jat/bkab073.
3
Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration.
非处方丁丙诺啡在刑事司法系统中的使用:最近刚从监禁中获释的个人的观点。
J Subst Abuse Treat. 2021 Aug;127:108349. doi: 10.1016/j.jsat.2021.108349. Epub 2021 Mar 4.
4
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.阿片类激动剂治疗与阿片类药物依赖患者全因死亡率及特定死因的相关性:系统评价和荟萃分析。
JAMA Psychiatry. 2021 Sep 1;78(9):979-993. doi: 10.1001/jamapsychiatry.2021.0976.
5
Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定尿液中的丁丙诺啡、去甲丁丙诺啡、纳洛酮及其葡萄糖醛酸结合物。
Drug Test Anal. 2021 Sep;13(9):1658-1667. doi: 10.1002/dta.3104. Epub 2021 Jun 3.
6
Concomitant drugs with buprenorphine user deaths.与丁丙诺啡使用者死亡相关的合并用药。
Drug Alcohol Depend. 2021 Jan 1;218:108345. doi: 10.1016/j.drugalcdep.2020.108345. Epub 2020 Oct 24.
7
Naloxone should remain the appropriate antidote to treat opioid overdose.纳洛酮应仍然是治疗阿片类药物过量的合适解毒剂。
Crit Care. 2020 Apr 28;24(1):173. doi: 10.1186/s13054-020-2835-5.
8
Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.肯塔基州进入基于惩教机构的药物治疗的成年人中丁丙诺啡转移使用情况的特征分析
Drug Alcohol Depend. 2020 Mar 1;208:107837. doi: 10.1016/j.drugalcdep.2020.107837. Epub 2020 Jan 9.
9
Use of urinary naloxone levels in a single provider practice: a case study.在单一医疗服务提供者实践中使用尿内纳洛酮水平:案例研究。
Addict Sci Clin Pract. 2020 Jan 15;15(1):3. doi: 10.1186/s13722-020-0178-9.
10
Overdose Risk and Client Characteristics Associated With the Injection of Buprenorphine at a Medically Supervised Injecting Center in Sydney, Australia.在澳大利亚悉尼的一家医疗监督注射中心,与丁丙诺啡注射相关的过量风险和客户特征。
Subst Use Misuse. 2019;54(10):1646-1653. doi: 10.1080/10826084.2019.1600147. Epub 2019 Apr 11.